These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6821353)

  • 1. 6-Hydroxydopamine lesions of dopaminergic A10 neurons. Long-term effects on the urinary excretion of free and conjugated catecholamines and their metabolites in the rat.
    Peyrin L; Simon H; Cottet-Emard JM; Bruneau N; Le Moal M
    Brain Res; 1982 Mar; 235(2):363-9. PubMed ID: 6821353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.
    Edwards DJ; Ravitch J; Knopf S; Sedlock ML
    Biochem Pharmacol; 1985 Apr; 34(8):1255-63. PubMed ID: 2581581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dopamine in intracranial self-stimulation of the ventral tegmental area.
    Fibiger HC; LePiane FG; Jakubovic A; Phillips AG
    J Neurosci; 1987 Dec; 7(12):3888-96. PubMed ID: 3121802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal and mesolimbic dopaminergic contribution to 3,4-dihydroxyphenylacetic acid sulfate in rat plasma.
    Boudet C; Simon H; Cottet-Emard JM; Dalmaz Y; Peyrin L
    Eur J Pharmacol; 1986 Feb; 121(1):113-8. PubMed ID: 3082654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.
    Hoeldtke R; Rogawski M; Wurtman RJ
    Br J Pharmacol; 1974 Feb; 50(2):265-70. PubMed ID: 4425765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.
    Peyrin L; Cottet-Emard JM; Javoy F; Agid Y; Herbet A; Glowinski J
    Brain Res; 1978 Mar; 143(3):567-72. PubMed ID: 274167
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat.
    Herve D; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1982 Apr; 237(2):510-6. PubMed ID: 6805852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
    Bacopoulos NG; Hattox SE; Roth RH
    Eur J Pharmacol; 1979 Jun; 56(3):225-36. PubMed ID: 477719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H; Jonsson G
    Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
    Chekhonin VP; Baklaushev VP; Kogan BM; Savchenko EA; Lebedev SV; Man'kovskaya IV; Filatova TS; Yusupova IU; Dmitrieva TB
    Bull Exp Biol Med; 2000 Aug; 130(8):805-9. PubMed ID: 11177250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary free and conjugated catecholamines and metabolites in autistic children.
    Barthelemy C; Bruneau N; Cottet-Eymard JM; Domenech-Jouve J; Garreau B; Lelord G; Muh JP; Peyrin L
    J Autism Dev Disord; 1988 Dec; 18(4):583-91. PubMed ID: 3215884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma catecholamines and urinary excretion of their main metabolites in three models of portal hypertension.
    Rodríguez-Puyol D; Alsasua A; Santos JC; Blanchart A; López-Novoa JM
    Clin Physiol Biochem; 1988; 6(6):301-9. PubMed ID: 3208482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neurons.
    Herman JP; Rivet JM; Abrous N; Le Moal M
    Neurosci Lett; 1988 Jul; 90(1-2):83-8. PubMed ID: 2901059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs.
    Yoshikawa M; Endo H; Komatsu K; Sugawara Y; Takaiti O
    J Pharmacobiodyn; 1990 Apr; 13(4):246-53. PubMed ID: 2384858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Hydroxydopamine lesion of the dopamine mesocorticolimbic cell bodies increases (+)-amphetamine self-administration.
    Deminière JM; Simon H; Herman JP; Le Moal M
    Psychopharmacology (Berl); 1984; 83(3):281-4. PubMed ID: 6433392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N; Nagasaka N
    ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free and conjugated catecholamines and metabolites in cat urine after hypoxia.
    Claustre J; Peyrin L
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Feb; 52(2):304-8. PubMed ID: 6800989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugated HVA increase in rat urine after insulin-induced hypoglycemia: involvement of central dopaminergic structures but not of adrenal medulla.
    Cottet-Emard JM; Peyrin L
    J Neural Transm; 1982; 55(2):121-38. PubMed ID: 6757386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.